Publications by authors named "Wanda Chan"

Claim this Profile
B
Bone Marrow Collection: Comparison of Unassisted vs Assisted Bedside Collections by a Laboratory Technologist.
Saba F Ali, Adam Cloe, Parwiz J Siaghani, Evan Himchak, David Cantu, Wanda Chan

Am J Clin Pathol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androstene-3,5-dienes as ER-beta selective SERMs.
Timothy A Blizzard, Candido Gude, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin

Bioorg Med Chem Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly potent growth hormone secretagogues.
Zhijian Lu, James R Tata, Kang Cheng, Liente Wei, Wanda W-S Chan

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridged androstenediol analogs as ER-beta selective SERMs.
Timothy A Blizzard, Candido Gude, Wanda Chan, Elizabeth T Birzin, Marina Mojena

Bioorg Med Chem Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERalpha.
Kevin D Dykstra, Liangqin Guo, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androstenediol analogs as ER-beta-selective SERMs.
Timothy A Blizzard, Candido Gude, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 14: application of novel antagonist side chains to existing platforms.
Timothy A Blizzard, Jerry D Morgan, Wanda Chan, Elizabeth T Birzin, Lee-Yuh Pai

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain.
Timothy A Blizzard, Frank DiNinno, Helen Y Chen, Seongkon Kim, Jane Y Wu, Wanda Chan

Bioorg Med Chem Lett· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 10: Chromanes: old scaffolds for new SERAMs.
Qiang Tan, Timothy A Blizzard, Jerry D Morgan, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 11: Synthesis and activity of isochromans and isothiochromans.
Jian Liu, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers.
Timothy A Blizzard, Frank Dininno, Jerry D Morgan, Helen Y Chen, Jane Y Wu, Wanda Chan

Bioorg Med Chem Lett· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains.
Timothy A Blizzard, Frank DiNinno, Jerry D Morgan, Helen Y Chen, Jane Y Wu, Wanda Chan

Bioorg Med Chem Lett· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains.
Timothy A Blizzard, Frank DiNinno, Jerry D Morgan, Jane Y Wu, Helen Y Chen, Wanda Chan

Bioorg Med Chem Lett· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 5: The SAR of dihydrobenzoxathiins containing modified basic side chains.
Qiang Tan, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Qiang Tan, Elizabeth T Birzin, Wanda Chan, Yi Tien Yang, Lee-Yuh Pai

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs.
Seongkon Kim, Jane Wu, Helen Y Chen, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.
Helen Y Chen, Seongkon Kim, Jane Y Wu, Elizabeth T Birzin, Wanda Chan

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Seongkon Kim, Jane Y Wu, Elizabeth T Birzin, Katalin Frisch, Wanda Chan

J Med Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 2-phenylspiroindenes and 2-phenylspiroindenediones as estrogen receptor ligands--modeling and binding data don't agree!
Timothy A Blizzard, Ralph T Mosley, Elizabeth T Birzin, Wanda Chan, Milton L Hammond

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity.
Helen Y Chen, Kevin D Dykstra, Elizabeth T Birzin, Katalin Frisch, Wanda Chan

Bioorg Med Chem Lett· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format.
Norbert T Peekhaus, Marc Ferrer, Tina Chang, Oleg Kornienko, Jonathan E Schneeweis, Wanda Chan

Assay Drug Dev Technol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
Zhijian Lu, James R Tata, Kang Cheng, Liente Wei, Wanda W-S Chan

Bioorg Med Chem Lett· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis